DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

160 Episodes

1. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
2. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
3. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
4. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
5. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
6. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
7. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
8. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
9. Unleashing Innovation: The Case for Permissionless R&D in Pharma

   Published: 3/22/2024
10. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024
11. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024
12. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024
13. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024
14. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024
15. LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

    Published: 3/8/2024
16. GELATIN-Free Medicines: Which Drugs Contain GELATIN?

    Published: 3/6/2024
17. Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

    Published: 2/26/2024
18. Drug Excipient Business Development Reports now Available on Amazon

    Published: 2/15/2024
19. Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters

    Published: 1/30/2024
20. Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

    Published: 1/22/2024